Does prostate size predict the urodynamic characteristics and clinical outcomes in benign prostate hyperplasia?

An 9-years-old male pug was examined for stranguria and letargic in one week. The dog has no testicles as the owner claimed that the dog had been castrated a few years ago. Abdominal palpation shows bladder retention filled with urine but no blockage was found. Urine sedimentation contained blood and few unknown crystal. Hematology showed mild anemia and leukocytosis while blood chemistry only found mild hyperglobulinemia. Radiography showed prostate enlargement. Ultrasound examination was showing mild nephrolithiasis, cystitis and prostatic enlargement. Diagnosis of benign prostate hyperplasia is suspected but doubtful because the animal has been castrated. Differential diagnose was prostatic cysts, infection and cancer. The dog received finasteride 1 mg/kg twice a day orally for 60 days and antibiotic. Urine catheter was temporarily installed to evacuate urine twice a day. Post treatment ultrasound was performed 20 days later and showed evident involution of prostate sizes. An enlarge irregular testicle was also found in right dorsolateral of bladder. Monorchid castration was performed at 60 days of finasteride. The dog was diagnosed with monorchid induce benign prostate hyperplasia from the radiography and ultrasonography. The prostate size was reduced after finasteride administration

Download Full-text

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia

Prostate International ◽

10.1016/j.prnil.2017.12.003 ◽

2018 ◽

Vol 6 (2) ◽

pp. 71-74 ◽

Cited By ~ 3

Author(s):

Suleyman Sami Cakir ◽

Emre Can Polat ◽

Levent Ozcan ◽

Huseyin Besiroglu ◽

Alper Ötunctemur ◽

...

Keyword(s):

Clinical Outcomes ◽

Benign Prostate Hyperplasia ◽

Prostate Hyperplasia ◽

Prostatic Inflammation ◽

Benign Prostate

Download Full-text

Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia

PRILOZI ◽

10.1515/prilozi-2017-0030 ◽

2017 ◽

Vol 38 (2) ◽

pp. 123-129 ◽

Cited By ~ 1

Author(s):

Skender Saidi ◽

Sotir Stavridis ◽

Oliver Stankov ◽

Sasho Dohcev ◽

Sasho Panov

Keyword(s):

Flow Rate ◽

Benign Prostate Hyperplasia ◽

Specific Antigen ◽

Maximum Flow ◽

Control Group ◽

Serenoa Repens ◽

Prostate Hyperplasia ◽

Alcohol Extract ◽

Prostate Size ◽

Benign Prostate

Abstract An increasing tendency has recently emerged for the use of phytotherapeutic agents as alternative to commercial pharmacological agents for the treatment of benign prostate hyperplasia (BPH). The purpose of this study is to evaluate the effects of Serenoa repens alcohol extract treatment on BPH patients’ symptoms and major parameters during one-year follow-up. The study was performed on 70 men aged 40 - 79 years (mean 60.58) with symptomatic BPH that were divided into a group of 40 patients treated with Serenoa repens extract (SRT) and a control group of 30 patients that received no treatment and were observed only. The following parameters were determined at the time of diagnosis (baseline), and after 6 and 12 months: prostate size, serum prostate-specific antigen (PSA) and uroflowmetry parameters including maximum flow rate (MFR), average flow rate (AFR) and post-voiding residual volume (PVRV). In addition, the relevant patient symptoms were evaluated using the International Prostate Symptom Score (IPSS) system. The patients in the SRT group showed a statistically significant increment of the average MFR and AFR values and reduction of PV relative to the control group (p<0.05). The significant differences between the proportion of patients with prostate volume >40 ml in the SRE treated group vs. control group was observed (p<0.05). The mean IPSS score was highly significantly reduced in the SRT group (p<0.01). The mild improvements of the urine flow, prostate size and IPSS score during 12 months treatment with the Serenoa repens extract indicate possible efficiency of this phytotherapeutic agent in patients with BPH.

Download Full-text

Comparison Between 1-Day and Inpatient Procedure of Holmium Laser Enucleation in Patients With Benign Prostate Hyperplasia

American Journal of Men s Health ◽

10.1177/1557988319894480 ◽

2019 ◽

Vol 13 (6) ◽

pp. 155798831989448

Author(s):

Jie Sun ◽

Zhen Tong ◽

An Shi ◽

Dong Li ◽

Wei Xue ◽

...

Keyword(s):

Clinical Outcomes ◽

Waiting Time ◽

Benign Prostate Hyperplasia ◽

Day Surgery ◽

Holmium Laser ◽

Prostate Hyperplasia ◽

Early Return ◽

Laser Enucleation ◽

Benign Prostate ◽

Holmium Laser Enucleation

Holmium laser enucleation of the prostate (HoLEP) is one of the minimally invasive procedures that is used for patients with benign prostate hyperplasia. The procedure usually requires patients to stay in the hospital 2 nights or longer. The present study evaluated the safety and feasibility of HoLEP with discharge of the patients on Day 1 after surgery (1-day surgery). A total of 1,164 patients were included in the study, with 510 of them planned for 1-day surgery and others planned for inpatient surgery. The primary outcomes included complication rate and clinical outcomes. A total 489 out of 510 patients received 1-day HoLEP and were discharged on Day 1 after surgery. In a 30-day follow-up period, no significant differences were found between the 1-day and inpatient surgery groups in terms of the rate of complications and clinical outcomes. Patients in the 1-day surgery group had a significantly shorter waiting time for admission (9.5 ± 4.8 vs. 17.6 ± 7.4 days, p < .05), and the mean hospitalization cost was lower (CNY$ 9140.6 ± 1452.2 vs. 10533.4 ± 1594, p < .05).The 1-day HoLEP surgery was safe and had satisfactory clinical outcomes. This treatment strategy could reduce the waiting time for admission and cost of hospitalization. Majority of the patients found this 1-day surgery beneficial, especially elderly patients who prefer to have an early return home and rapid resumption of activities.

Download Full-text

HUBUNGAN USIA, OBESITAS DAN RIWAYAT PENYAKIT DIABETES MELLITUS DENGAN KEJADIAN BENIGN PROSTATE HYPERPLASIA (BPH) DERAJAT IV DI RSUD DR. M. HAULUSSY AMBON PERIODE 2012-2014

MOLUCCA MEDICA ◽

10.30598/molmed.2017.10.2.141 ◽

2017 ◽

pp. 141-151

Author(s):

Andrew Ruspanah

Keyword(s):

Diabetes Mellitus ◽

Benign Prostate Hyperplasia ◽

Chi Square ◽

Cross Sectional ◽

Prostate Hyperplasia ◽

Benign Prostate

Pendahuluan. Benign Postate Hiperplasia (BPH) adalah penyakit yang umumnya terjadi pada pria lansia yang disebabkan oleh penuaan. Hiperplasia prostat adalah pertumbuhan jaringan nodul fibroadenomatosa pada prostat. Pembesaran prostat jinak merupakan penyakit yang tersering kedua setelah batu saluran kemih didapatkan secara klinis di Indonesia. Tujuan. Penelitian ini bertujuan untuk mengetahui hubungan antara usia, obesitas dan riwayat diabetes mellitus dengan kejadian Benign Prostate Hyperplasia (BPH) grade IV di Rumah Sakit Dr. M. Haulussy Ambon periode 2012-2014. Metode. Jenis penelitian ini adalah penelitian analitik desain Cross-Sectional, dengan menggunakan catatan medis data di ruang operasi di Rumah Sakit Dr. M. Haulussy Ambon Tahun 2012-2014 dan memperoleh jumlah sampel yang memenuhi kriteria inklusi sebanyak 239, yang diambil dengan teknik total sampling. Analisis dilakukan dengan analisis univariat dan bivariat menggunakan uji Chi Square. Hasil yang di temukan dalam penelitian ini bahwa kejadian BPH lebih besar pada mereka yang berusia> 65 tahun dan 56-65 tahun dibandingkan dengan usia 46-55 dan <46 tahun dengan hasil tes menunjukkan adanya hubungan antara usia dengan BPH dengan nilai (p= 0,000), ada hubungan antara obesitas dengan nilai BPH (p=0,019) dan riwayat diabetes mellitus setelah menggunakan uji Chi-Square, hubungan antara riwayat diabetes mellitus dengan BPH dengan nilai (p = 0,000). Kesimpulan. Ada hubungan antara umur, obesitas dan riwayat diabetes mellitus dengan kejadian BPH.

Download Full-text